Xbiom Accelerating Innovation in BioPharma
Whitepaper
Smart Transformation of Disparate Biopharma Source Data to Unified Machine Readable Target Data Models
Whitepaper - June 20, 2019
Xbiom â A Workbench for Translational and Biomarker Research
2 PAGE BROUCHER
Smart Transformation of Clinical & Nonclinical Data for Insights
PhUSE US Connect - February 2019
Xbiom â A Biomarker Research Workbench for BioTechs and BioPharma
This draft white paper from PointCross Life Sciences Inc. (Foster City, CA) presents the opportunities for biomarker and biologics based therapeutic development using search analytics and data integration of clinical and biomarker data as available in its Xbiom solution
PhUSE paper- Ensuring consistency of SEND Datasets with Study Reports using Machine Learning Algorithms
PhUSE paper- Ensuring consistency of SEND Datasets with Study Reports using Machine Learning Algorithms
PhUSE CSS March Poster_Ensuring consistency of SEND Datasets
PhUSE CSS March Poster_Ensuring consistency of SEND Datasets with Study Reports using Machine Learning Algorithms
Standards and Ontology Driven Workflow Automation of Clinical Studies
Standards and Ontology Driven Workflow Automation of Clinical Studies - PointCross Life Sciences
Xbiom⢠for Molecular Biomarker Research in Precision Medicine
There is a perfect storm brewing where advances in genomic screening, identifying molecular biomarkers and precisely targeted medicines and diagnostics, smart monitoring of patient vitals and physiology using devices such as smart phones and...
Enabling Data Integration for Translational & Precision Medicine
Webinar Recording May 2021
Xbiom Workbench
Data Hub for Clinical, Translational and Biomarker Research- View Video
Xbiom Smart Transformation
Rapidly map legacy and raw data to CDISC standards - View Video
Smart Transformation Of Your Disparate Data Into Unified Form For Repurposing
Thursday, June 13 at 8:00am PT/ 11:0am ET
How to Integrate Clinical, Biomarker, and Other Disparate Data Sources
Title: How to Integrate Clinical, Biomarker, and Other Disparate Data Sources May 16, 2017
EDC Raw Data to SDTM Curation, Mapping and Automation with the Xbiom Tool
At PHUSE US Connect 2023, PointCross Life Sciences presented a new way to automate the mapping of raw clinical EDC and non-EDC (biomarker) data to SDTM mapping through a Universal Data Model (UDM). Reducing the time to SDTM from weeks to days with built-in traceability, we discussed how SDTM programming and mapping for statistical analysis...
Molecular Medicine Tri-Con
A Universal Data Model for Longitudinal Integration of Disparate Biomarker and In-Life Patient Data Augmented by Machine Learning | 17th, February 2021
PHUSE US Connect 2020 -DH12: Validation Consistency and Conformance Checking of SEND Datasets
DH12: Validation Consistency and Conformance Checking of SEND Datasets
PhUSE EU Connect: Amsterdam
November 10 -13 | A live demo of our offerings or learning more about the release of our eDataValidator.
PhUSE Single day event
Beerse, Belgium | September 11, 2019
PhUSE 2019 Computational Science Symposium
Booth #9, Silver Spring Civic Center June 9-11, 2019 | Silver Spring, MD
Bayer Data Insights Event Berlin
Bayer held an internal âinvitee onlyâ day to discuss, celebrate, and share the possibilities and use cases of PORTIN â a portal for translational data integration. PORTIN is built on PointCross Xbiom with integration to various enterprise data ...
Bio-IT World Conference an Expo â 2019
Booth #638 | April 15-18, 2019 | Boston, MA
AWS and PointCross Workshop at Boston
April 17, 2019 | 8:00 am â 9:30am ET | Boston, MA 02210
Phuse SDE
April 4, 2019 | Foster City, California
PhUSE Connect EU â The Clinical Data Science Conference
November 4 â 8, 2018 | KAP Europa | Frankfurt, Germany
The Molecular Medicine Tri Con Conference 2018
Feb 11 â 16, 2018 | San Francisco, CA | Booth # 732
PhuSE Single Day Event Foster City
Feb 22, 2018 | Foster City Community Center | Wind Room
PhUSE CSS Computational Science Symposium
March 4 â 6, 2018 | Silver Spring, MD
PointCross releases eDataValidator for SDTM, ADaM, SEND, and Define.XML conformance to prevailing FDA, CDISC, and PMDA rules
PointCross Life Sciences has released the full complement of its eDataValidator⢠(eDV) for validating SDTM, ADaM, SEND and Define.XML data for conformance to prevailing FDA, CDISC, and PMDA rules. In use by 5 of the top 10 large pharma and CROs, eDV has now been released as a standalone tool in response to growing demand from sponsor Clinical...
FDA to enforce the Technical Rejection Criteria (TRC) beginning Sept 15th, 2021
FDA to enforce the Technical Rejection Criteria (TRC) beginning Sept 15th, 2021 (Â Technical Rejection Criteria for Study Data) The TRC has been added to the existing eCTD validation criteria to enforce compliance with the SEND requirements for study types modelled in an FDA supported SEND Implementation Guide (SENDIG) version. Any electronic submission submitted after Sept 15th,...
Effective March 15, 2021: Support for SEND DART IG 1.1 per FDA Data Standards Catalog
Effective March 15, 2021: Support for SEND DART IG 1.1 per FDA Data Standards Catalog (Â FDA Announcement;Â FDA Data Standards Catalog) Our Software solution (Xbiom) and services are set up to accommodate DART IG 1.1, and we have been generating SEND datasets for DART studies including EFD, Fertility and Early Embryonic Development and Pre-Natal and Post Natal...
PointCross Life Sciencesâ Clinical Data Repository for SDTM data fills an urgent gap
CIMSâ˘, the PointCross Life Science built Repository for Clinical SDTM Data is now available to Pharma sponsors with compliant standardized NDA submissions to FDA guidance. Silver Spring, MD, March 14, 2016 PointCross Life Sciences today announced its formal release of CIMSâ˘, a Hadoop (HDFS) based extensible repository. CIMS has extensive workflows and validations systems built-in for...
PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development
Xbiom⢠and iOmics⢠integration arcs across nonclinical, clinical and genomic biomarkers for targeted therapeutic drug development and stratified patient selection Foster City, CA, April 20, 2015 /PRNewswire/ â PointCross Life Sciences today announced a strategic partnership with InterpretOmics Pvt. Ltd. to provide an integrated Big Data and globally accessible environment for genomic interpretation and analysis...